142 related articles for article (PubMed ID: 2853743)
1. Partial purification and properties of a plasma ouabain-like inhibitor of Na+, K+-ATPase in patients with essential hypertension.
Masugi F; Ogihara T; Sakaguchi K; Tomii A; Hasegawa T; Chen Y; Azuma M; Kumahara Y
J Hypertens Suppl; 1988 Dec; 6(4):S351-3. PubMed ID: 2853743
[TBL] [Abstract][Full Text] [Related]
2. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
4. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
5. Ouabain-like Na+,K(+)-ATPase inhibitory activity of a plasma extract in normal pregnancy and pregnancy induced hypertension.
Miyagi H; Higuchi M; Nakayama M; Moromizato H; Sakanashi M
Jpn J Pharmacol; 1991 Dec; 57(4):571-81. PubMed ID: 1666421
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of a digitalis-like substance in human urine, partially purified by high pressure liquid chromatography.
Takeda R; Morise T; Ikeda M; Okamoto S
Cardiology; 1989; 76(6):442-9. PubMed ID: 2558793
[TBL] [Abstract][Full Text] [Related]
7. Digoxin-like immunoreactivity, displacement of ouabain and inhibition of Na+/K+ ATPase by four steroids known to be increased in essential hypertension.
Seccombe DW; Pudek MR; Nowaczynski W; Humphries KH
Clin Biochem; 1989 Feb; 22(1):17-21. PubMed ID: 2539926
[TBL] [Abstract][Full Text] [Related]
8. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
[TBL] [Abstract][Full Text] [Related]
9. Ouabain-like and non-ouabain-like factors in plasma of patients with essential hypertension.
Masugi F; Ogihara T; Hasegawa T; Kumahara Y
Clin Exp Hypertens A; 1987; 9(7):1233-42. PubMed ID: 3040306
[TBL] [Abstract][Full Text] [Related]
10. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
13. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
[TBL] [Abstract][Full Text] [Related]
14. [Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].
Kramer HJ; Bäcker A; Krampitz G; Meyer-Lehnert H; Michel H
Klin Wochenschr; 1990 Nov; 68(22):1112-8. PubMed ID: 2177810
[TBL] [Abstract][Full Text] [Related]
15. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
16. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
Hallaq HA; Haupert GT
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
[TBL] [Abstract][Full Text] [Related]
17. The pathophysiological role of digitalis-like substance in essential hypertension.
Saitoh S; Shimamoto K; Nakagawa M; Yamaguchi Y; Matsuda K; Kuroda S; Ura N; Iimura O
J Hypertens Suppl; 1988 Dec; 6(4):S360-2. PubMed ID: 2853746
[TBL] [Abstract][Full Text] [Related]
18. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
Gonick HC; Weiler EW; Prins BA; Purdy RE
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
[TBL] [Abstract][Full Text] [Related]
19. Endogenous digitalis-like factors in hypertension and chronic renal insufficiency.
Kelly RA; O'Hara DS; Mitch WE; Steinman TI; Goldszer RC; Solomon HS; Smith TW
Kidney Int; 1986 Nov; 30(5):723-9. PubMed ID: 3023736
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
Meyer-Lehnert H; Bäcker A; Kramer HJ
Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]